Literature DB >> 9573374

The human RIL gene: mapping to human chromosome 5q31.1, genomic organization and alternative transcripts.

A A Bashirova1, M L Markelov, T V Shlykova, E V Levshenkova, R A Alibaeva, E I Frolova.   

Abstract

The ril gene encoding a LIM domain protein of an unknown function was previously identified by differential expression cloning as a candidate tumor suppressor gene in rat fibroblasts (Kiess, M., Scharm, B., Aguzzi, A., Hajnal, A., Klemenz, R., Schwarte-Waldhoff, I., Schafer, R., 1995. Expression of ril, a novel LIM domain gene, is down-regulated in HRAS-transformed cells and restored in phenotypic revertants. Oncogene 10, 61-68). Searching for novel genes on human chromosome 5q31.1 by the cDNA selection technique, we isolated a cDNA clone identical with the cDNA of the human RIL gene (GenBank Accession No. X93510). The human 5q31.1 region is of interest because it contains the cytokine gene cluster and is frequently deleted in the malignant cells of patients with myelodysplasia and myeloid leukemia. Using Southern blot analysis and restriction mapping of genomic YAC (yeast artificial chromosome) and cosmid clones, we located the human RIL gene 240-260 kb telomeric to the IRF1 gene and characterized its genomic structure. PCR analysis indicated the presence of two alternative RIL transcripts in human fetal brain mRNA. The major transcript is identical with the RIL cDNA previously deposited in GenBank and contains seven exons distributed over 14.5 kb of genomic DNA with the two last 3'-exons coding a LIM domain. The minor transcript lacks the sixth exon compared with the major transcript, which leads to the loss of the LIM domain. We also identified two putative transcription start points (tsp) and sequenced the 5'-flanking region of RIL to reveal potential binding sites for transcriptional factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573374     DOI: 10.1016/s0378-1119(98)00080-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4/RIL protein.

Authors:  Olga A Guryanova; Judith A Drazba; Elena I Frolova; Peter M Chumakov
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Molecular cloning and characterization of a novel human kinase gene, PDIK1L.

Authors:  Lingchen Guo; Chaoneng Ji; Shaohua Gu; Kang Ying; Haipeng Cheng; Xiaoghua Ni; Jianping Liu; Yi Xie; Yumin Mao
Journal:  J Genet       Date:  2003 Apr-Aug       Impact factor: 1.166

3.  Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women.

Authors:  Fumihiro Omasu; Yoichi Ezura; Mitsuko Kajita; Ryota Ishida; Mina Kodaira; Hideo Yoshida; Takao Suzuki; Takayuki Hosoi; Satoshi Inoue; Masataka Shiraki; Hajime Orimo; Mitsuru Emi
Journal:  J Hum Genet       Date:  2003-06-06       Impact factor: 3.172

4.  [Down-regulation of TRIP6 expression induces actin cytoskeleton rearrangements in human carcinoma cell lines].

Authors:  O A Gur'ianova; A A Sablina; P M Chumakov; E I Frolova
Journal:  Mol Biol (Mosk)       Date:  2005 Sep-Oct

5.  Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth.

Authors:  Gary Loughran; Nollaig C Healy; Patrick A Kiely; Merei Huigsloot; Nancy L Kedersha; Rosemary O'Connor
Journal:  Mol Biol Cell       Date:  2005-01-19       Impact factor: 4.138

6.  Molecular characterization of the Caenorhabditis elegans ALP/Enigma gene alp-1.

Authors:  Caroline R McKeown; Hsiao-Fen Han; Mary C Beckerle
Journal:  Dev Dyn       Date:  2006-02       Impact factor: 3.780

7.  PDLIM4, an actin binding protein, suppresses prostate cancer cell growth.

Authors:  Donkena Krishna Vanaja; Michael E Grossmann; John C Cheville; Mozammel H Gazi; Aiyu Gong; Jin San Zhang; Katalin Ajtai; Thomas P Burghardt; Charles Y F Young
Journal:  Cancer Invest       Date:  2009-03       Impact factor: 2.176

Review 8.  ALP/Enigma PDZ-LIM domain proteins in the heart.

Authors:  Ming Zheng; Hongqiang Cheng; Indroneal Banerjee; Ju Chen
Journal:  J Mol Cell Biol       Date:  2009-12-30       Impact factor: 6.216

9.  Characterization of the interaction between Actinin-Associated LIM Protein (ALP) and the rod domain of alpha-actinin.

Authors:  Tuula Klaavuniemi; Nanna Alho; Pirta Hotulainen; Annina Kelloniemi; Heli Havukainen; Perttu Permi; Sampo Mattila; Jari Ylänne
Journal:  BMC Cell Biol       Date:  2009-03-27       Impact factor: 4.241

10.  An Sp1/Sp3 binding polymorphism confers methylation protection.

Authors:  Yanis A Boumber; Yutaka Kondo; Xuqi Chen; Lanlan Shen; Yi Guo; Carmen Tellez; Marcos R H Estécio; Saira Ahmed; Jean-Pierre J Issa
Journal:  PLoS Genet       Date:  2008-08-22       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.